Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain

(2011) Carmen Muñoz-Almagro et al.   JOURNAL OF INFECTION

Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

(2010) Mark H. Rozenbaum et al.   CLINICAL THERAPEUTICS

Modelling the effect of conjugate vaccines in pneumococcal disease: Cohort or population models?

(2010) Baudouin Standaert et al.   VACCINE

The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003–2007)

(2010) Ruth Gil-Prieto et al.   VACCINE

Utilización del cuestionario European Quality of Life-5 Dimensions (EQ-5D) para valorar la variación de la calidad de vida relacionada con la salud debida a la gripe

(2009) Roberto Pradas Velasco et al.   Gaceta Sanitaria

Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias

(2009) Julio López Bastida et al.   Gaceta Sanitaria

Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006

(2009) Caroline L. Trotter et al.   JOURNAL OF INFECTION

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations

(2009) Sonya J. Snedecor et al.   VACCINE